Evidence map›Paper›PMID 41602276›Full record

ArticleMedical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention2024

Insight: A Multi-Modal Diagnostic Pipeline using LLMs for Ocular Surface Disease Diagnosis.

Chun-Hsiao Yeh, Jiayun Wang, Andrew D Graham, Andrea J Liu, Bo Tan, Yubei Chen, Yi Ma, Meng C Lin

Abstract read
In one paragraph

Article in Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chun-Hsiao YehClinical Research Center, University of California, Berkeley, Berkeley, CA, USA.
Jiayun WangClinical Research Center, University of California, Berkeley, Berkeley, CA, USA.
Andrew D GrahamClinical Research Center, University of California, Berkeley, Berkeley, CA, USA.
Andrea J LiuClinical Research Center, University of California, Berkeley, Berkeley, CA, USA.
Bo TanClinical Research Center, University of California, Berkeley, Berkeley, CA, USA.
Yubei ChenUniversity of California, Davis, Davis, CA, USA.
Yi MaUniversity of California, Berkeley, Berkeley, CA, USA.
Meng C LinClinical Research Center, University of California, Berkeley, Berkeley, CA, USA.

Funding

A Second Look at DREAM: Towards a New Paradigm in Meibomian Gland Evaluation Using Artificial IntelligenceR21EY033881 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI LIN, MENG CHING, YU, STELLA · 2022 to 2023
$398k
NEI NIH HHS R21 EY033881
6 · The paper itself

Abstract

Accurate diagnosis of ocular surface diseases is critical in optometry and ophthalmology, which hinge on integrating clinical data sources (e.g., meibography imaging and clinical metadata). Traditional human assessments lack precision in quantifying clinical observations, while current machine-based methods often treat diagnoses as multi-class classification problems, limiting the diagnoses to a predefined closed-set of curated answers without reasoning the clinical relevance of each variable to the diagnosis. To tackle these challenges, we introduce an innovative multi-modal diagnostic pipeline (MDPipe) by employing large language models (LLMs) for ocular surface disease diagnosis. We first employ a visual translator to interpret meibography images by converting them into quantifiable morphology data, facilitating their integration with clinical metadata and enabling the communication of nuanced medical insight to LLMs. To further advance this communication, we introduce a LLM-based summarizer to contextualize the insight from the combined morphology and clinical metadata, and generate clinical report summaries. Finally, we refine the LLMs' reasoning ability with domain-specific insight from real-life clinician diagnoses. Our evaluation across diverse ocular surface disease diagnosis benchmarks demonstrates that MDPipe outperforms existing standards, including GPT-4, and provides clinically sound rationales for diagnoses. The project is available at https://danielchyeh.github.io/MDPipe/.

Indexed as

Large Language ModelsMultimodalityOcular Surface Disease Diagnosis

Identifiers

PMID41602276
PMCPMC12832216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.